ArticleBritish journal of anaesthesia2025
Impact of peripheral nerve blocks on chronic opioid use after elective total knee arthroplasty from a large US claims database.
Article in British journal of anaesthesia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Esketamine as an Adjuvant to Ropivacaine in Genicular Nerve and IPACK Blocks for Total Knee Arthroplasty: A Double-Blind Randomized Trial.Drug design, development and therapy · 2025Trial
- Impact of peripheral nerve blocks on chronic opioid use after elective total knee arthroplasty from a large US claims database. Comment on Br J Anaesth 2025; 134: 1779-83.British journal of anaesthesia · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeripheral nerve blocks (PNBs), either single-shot injection or continuous catheter infusion, are increasingly used in total knee arthroplasties (TKAs). Although recent data show equivalence between both modalities in immediate perioperative analgesia, comparative data on longer-term outcomes such as chronic opioid use are scarce.
methodsUsing US Merative MarketScan commercial claims data (2018-22; n=126 860 TKAs), we compared: (1) patients receiving PNB vs those who did not; and (2) single-shot vs continuous catheter infusion PNB. Primary outcomes were: (1) 'chronic opioid dependence' (>120 pills of opioids prescribed or >10 prescriptions between postoperative day 90 and 180); and (2) 'chronic opioid use' (any opioid refill between postoperative day 90 and 180). Multivariable models measured associations between PNB modalities and outcomes.
resultsIncidence of 'chronic opioid dependence' was 0.7%, 0.8%, and 0.9% among patients without PNB, with single-shot PNB, and with continuous PNB, respectively. For 'chronic opioid use', this was 12.6%, 13.8%, and 14.3%. Multivariable analyses indicated no association between PNB (yes/no and modality) utilisation and 'chronic opioid dependence'. However, single-shot (OR 1.01, 95% CI 1.01-1.02; P<0.001) and continuous PNB (OR 1.01, 95% CI 1.01-1.02; P<0.001) compared with no PNB use were associated with slightly higher odds of 'chronic opioid use'. DISCUSSION: Our results did not show any clinically meaningful differences in postoperative chronic opioid use or dependence across patients receiving single-shot PNB or continuous PNB treatment. Future prospective registry data might be indicated to further address this question.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.